Diatech Diabetes Revenue and Competitors

Diatech Diabetes, Inc. develops innovative solutions that empower the lives of patients, families, and communities impacted by diabetes. Having originated from the issues our founders faced with their own diabetes care technology, Diatech Diabetes is inspired to work endlessly towards optimizing therapies for patients worldwide.\n\nCurrent insulin pump infusion sets and occlusion alarms can compromise the health of a person with diabetes during insulin pump failures. These failures range from blocks, leaks, and infusing into damaged tissue affected by lipohypertrophy that may prevent insulin from being absorbed into the body.\n\nDiatech Diabetes is developing SMARTFUSION™, a software platform for insulin pumps that monitors insulin delivery for accuracy and infusion set failure. When SMARTFUSION™'s software is integrated into an insulin pump system, its algorithm uses data from the pump, continuous glucose monitor, and patient to monitor the success of daily insulin dosages.\n\nSMARTFUSION™’s features will include:\n- Alerts to other malfunctions such as leaks and improper insertion\n- Reviewable data on how infusion performance/habits affect diabetes control\n- Instant infusion failure alerts to connected devices\n- Custom settings to prevent alarm fatigue \n- Infusion set wear time recommendations\n- Personalized tips for healthy infusion based on habits\n\nThese features could allow insulin pump users to know the exact time at which their infusion set needs to be changed and when infusion accuracy is lost to avoid potentially life-threatening blood sugar. \n\nFor healthcare providers, SMARTFUSION™ allows for the collection of data related to infusion site health and characterizing malfunctions for each of their patients. This data could be uploaded through diabetes management platforms during check-ups and assist providers with ensuring their patients are accurately using insulin pump technology.\n\nSMARTFUSION™ is Not Currently Proven for Human Use.